Analysis: Highest rate increases will be from national carriers with co-ops and Blues not far behind.
Health Care + Med Tech
Anthony Cataldo of Oxis Biotech touts immunotherapies targeting lymphoma and leukemia.
Is this harmony in health care?
The medtech company will receive the state funds once it has accomplished its promise to create 120 new jobs at the site.
The company hopes the semantic coding specialist will help push its electronic health records system to market in other countries.
Construction on the six-block research, education, commercial and product development space is set to start in late 2017.
The school claimed Gilead Sciences used a drug it developed to create and heavily profit off of Hepatitis C medications.
New report adds to evidence that employees are paying more for their own care.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.
Evelo Biosciences joins four others as investment, research dollars flow into field.
The deal could see the fluid management company expanding its product sales to government organizations, including contracts with budgets totaling $33 billion.
Prime’s CEO said the partnership could allow it to slow down “this run-away freight train of rising drug costs.”
This company also recently completed its acquisition of HeartWare.
The med-tech company expected to complete the deal in late October.
Study links use of mind-body practices for chronic conditions with more missed days of work.
The bioengineering company is looking to raise about $3.7 million, according to a recent SEC filing.
After launch of Unity Biotechnology, study links osteoarthritis to ‘senescent’ cells.
Danish company sees local office as part of global growth.